Cargando…
Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
BACKGROUND: This article about the emerging field of cardio-oncology highlights typical side effects of oncological therapies in the cardiovascular system, cardiovascular complications of malignancies itself, and potential preventive or therapeutic modalities. METHODS: We performed a selective liter...
Autores principales: | Tilemann, Lisa M., Heckmann, Markus B., Katus, Hugo A., Lehmann, Lorenz H., Müller, Oliver J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869944/ https://www.ncbi.nlm.nih.gov/pubmed/29453595 http://dx.doi.org/10.1007/s00392-018-1202-x |
Ejemplares similares
-
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010) -
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019) -
Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2019) -
Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease
por: Heckmann, Markus B., et al.
Publicado: (2020) -
Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)